Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 5230.0
(7.84%)
JPY 5230.0
(7.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -34.43 Billion JPY | -73.09% |
| 2022 | -19.89 Billion JPY | 26.0% |
| 2021 | -26.88 Billion JPY | 14.05% |
| 2020 | -31.28 Billion JPY | 27.57% |
| 2019 | -43.19 Billion JPY | -254.36% |
| 2018 | -12.18 Billion JPY | 22.59% |
| 2017 | -15.74 Billion JPY | 45.17% |
| 2016 | -28.71 Billion JPY | -62.76% |
| 2015 | -17.64 Billion JPY | 14.26% |
| 2014 | -20.57 Billion JPY | 0.69% |
| 2013 | -20.72 Billion JPY | -72.44% |
| 2012 | -12.01 Billion JPY | 61.67% |
| 2011 | -31.34 Billion JPY | -31.76% |
| 2010 | -23.79 Billion JPY | 44.49% |
| 2009 | -42.85 Billion JPY | -847.72% |
| 2008 | -4.52 Billion JPY | 25.69% |
| 2007 | -6.08 Billion JPY | 28.5% |
| 2006 | -8.51 Billion JPY | -17.67% |
| 2005 | -7.23 Billion JPY | 53.32% |
| 2004 | -15.49 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -3.38 Billion JPY | 90.16% |
| 2024 Q2 | -32.63 Billion JPY | -863.45% |
| 2024 Q3 | -4.99 Billion JPY | 84.69% |
| 2023 Q4 | -34.43 Billion JPY | -537.6% |
| 2023 Q1 | -9.54 Billion JPY | 52.05% |
| 2023 Q3 | -5.4 Billion JPY | 24.02% |
| 2023 FY | -34.43 Billion JPY | -73.09% |
| 2023 Q2 | -7.1 Billion JPY | 25.5% |
| 2022 Q2 | -23.97 Billion JPY | -1.42% |
| 2022 Q4 | -19.89 Billion JPY | 4.21% |
| 2022 FY | -19.89 Billion JPY | 26.0% |
| 2022 Q1 | -23.64 Billion JPY | 12.06% |
| 2022 Q3 | -20.77 Billion JPY | 13.38% |
| 2021 Q4 | -26.88 Billion JPY | 9.64% |
| 2021 FY | -26.88 Billion JPY | 14.05% |
| 2021 Q1 | -28.74 Billion JPY | 8.12% |
| 2021 Q2 | -27.64 Billion JPY | 3.83% |
| 2021 Q3 | -29.75 Billion JPY | -7.64% |
| 2020 Q2 | -29.85 Billion JPY | 6.94% |
| 2020 Q1 | -32.08 Billion JPY | 25.72% |
| 2020 FY | -31.28 Billion JPY | 27.57% |
| 2020 Q4 | -31.28 Billion JPY | 1.72% |
| 2020 Q3 | -31.83 Billion JPY | -6.6% |
| 2019 Q4 | -43.19 Billion JPY | -5.83% |
| 2019 FY | -43.19 Billion JPY | -254.36% |
| 2019 Q2 | -33.2 Billion JPY | 20.25% |
| 2019 Q1 | -41.63 Billion JPY | -241.64% |
| 2019 Q3 | -40.81 Billion JPY | -22.9% |
| 2018 Q4 | -12.18 Billion JPY | -14.22% |
| 2018 FY | -12.18 Billion JPY | 22.59% |
| 2018 Q1 | -8.34 Billion JPY | 46.97% |
| 2018 Q2 | -5.7 Billion JPY | 31.7% |
| 2018 Q3 | -10.67 Billion JPY | -87.14% |
| 2017 Q4 | -15.74 Billion JPY | 29.31% |
| 2017 Q2 | -21.91 Billion JPY | 18.05% |
| 2017 Q1 | -26.74 Billion JPY | 6.86% |
| 2017 Q3 | -22.27 Billion JPY | -1.62% |
| 2017 FY | -15.74 Billion JPY | 45.17% |
| 2016 Q3 | -26.58 Billion JPY | 13.96% |
| 2016 FY | -28.71 Billion JPY | -62.76% |
| 2016 Q2 | -30.89 Billion JPY | -39.17% |
| 2016 Q4 | -28.71 Billion JPY | -8.01% |
| 2016 Q1 | -22.2 Billion JPY | -25.85% |
| 2015 Q2 | -18.71 Billion JPY | -7.97% |
| 2015 Q3 | -17.07 Billion JPY | 8.75% |
| 2015 Q1 | -17.33 Billion JPY | 0.0% |
| 2015 FY | -17.64 Billion JPY | 14.26% |
| 2015 Q4 | -17.64 Billion JPY | -3.32% |
| 2014 Q1 | -20.72 Billion JPY | -14.79% |
| 2014 FY | -20.57 Billion JPY | 0.69% |
| 2014 Q3 | -29.9 Billion JPY | -42.92% |
| 2014 Q2 | -20.92 Billion JPY | -0.98% |
| 2013 Q4 | -18.05 Billion JPY | 26.39% |
| 2013 Q1 | -12.01 Billion JPY | 54.92% |
| 2013 Q2 | -11.98 Billion JPY | 0.28% |
| 2013 Q3 | -24.52 Billion JPY | -104.65% |
| 2013 FY | -20.72 Billion JPY | -72.44% |
| 2012 Q3 | -30.09 Billion JPY | -3.64% |
| 2012 FY | -12.01 Billion JPY | 61.67% |
| 2012 Q4 | -26.65 Billion JPY | 11.43% |
| 2012 Q2 | -29.03 Billion JPY | 7.37% |
| 2012 Q1 | -31.34 Billion JPY | -50.69% |
| 2011 Q3 | -24.31 Billion JPY | -89.75% |
| 2011 FY | -31.34 Billion JPY | -31.76% |
| 2011 Q1 | -23.79 Billion JPY | -7.69% |
| 2011 Q2 | -12.81 Billion JPY | 46.15% |
| 2011 Q4 | -20.8 Billion JPY | 14.43% |
| 2010 Q1 | -42.85 Billion JPY | -221.65% |
| 2010 Q3 | -14.38 Billion JPY | -108.15% |
| 2010 Q4 | -22.09 Billion JPY | -53.6% |
| 2010 FY | -23.79 Billion JPY | 44.49% |
| 2010 Q2 | -6.91 Billion JPY | 83.88% |
| 2009 Q4 | -13.32 Billion JPY | -53.63% |
| 2009 FY | -42.85 Billion JPY | -847.72% |
| 2009 Q3 | -8.67 Billion JPY | 0.0% |
| 2009 Q1 | -4.52 Billion JPY | 21.04% |
| 2008 FY | -4.52 Billion JPY | 25.69% |
| 2008 Q4 | -5.72 Billion JPY | 0.0% |
| 2007 FY | -6.08 Billion JPY | 28.5% |
| 2006 FY | -8.51 Billion JPY | -17.67% |
| 2005 FY | -7.23 Billion JPY | 53.32% |
| 2004 FY | -15.49 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 2911.184% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 100.785% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 108.834% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 90.061% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -866.214% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | 18.311% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 43.981% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 64.836% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -5062.969% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 33.546% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -4.605% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 552.999% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 542.578% |
| Tsumura & Co. | 1.61 Billion JPY | 2232.322% |
| Kissei Pharmaceutical Co., Ltd. | -44.16 Billion JPY | 22.018% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 119.94% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 229.346% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 218.823% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 587.776% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 4991.619% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 674.716% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -428.417% |
| MedRx Co., Ltd | -1.72 Billion JPY | -1902.151% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -295.08% |
| Solasia Pharma K.K. | -668 Million JPY | -5055.24% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -2241.161% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -374.797% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 160.927% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -1063.108% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 65.013% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -209.418% |